March 9, 2026

New study offers strong evidence of elevated heart failure risk in adults with prediabetes, hypertension and subclinical heart injury or stress

March 9, 2026 / Research update / InnovateMed Author / prediabetes

Johns Hopkins Medicine researchers say their findings highlight an overlooked population of at-risk adults with prediabetes who could easily be identified using common cardiac biomarkers Peer-Reviewed Publication Johns Hopkins Medicine A new study from researchers led by Johns Hopkins Medicine reports substantial new evidence that elevated blood biomarkers of subclinical heart injury or stress — […]

New study offers strong evidence of elevated heart failure risk in adults with prediabetes, hypertension and subclinical heart injury or stress Read More »

Study reveals how antibiotic use during leukemia treatment reshapes the gut microbiome

March 9, 2026 / Research update / InnovateMed Author / leukemia

by Camryn Haines, Texas A&M University edited by Lisa Lock, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source The total number of antibiotic administrations among AR-colonization outcome groups. Of the patients who received (A) carbapenem administrations (B) oxazolidinone administrations, and (C) tetracycline administrations, the total administrations of each antibiotic were compared between patients who

Study reveals how antibiotic use during leukemia treatment reshapes the gut microbiome Read More »

Immune cells play key role in regulating eye pressure linked to glaucoma, research reveals

March 9, 2026 / Research update / InnovateMed Author / glaucoma

by Duke University Medical Center edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Katy Liu, M.D., Ph.D., reviews samples in a lab at Duke University. Credit: Duke Health When the eye’s drainage system clogs, pressure builds up and causes damage. The pressure can lead to glaucoma and vision loss. New

Immune cells play key role in regulating eye pressure linked to glaucoma, research reveals Read More »

Heart and metabolic risk factors more strongly linked to liver fibrosis in women than men, study finds

March 9, 2026 / Research update / InnovateMed Author / fibrosis

Researchers from the Keck School of Medicine of USC studied sex differences in type 2 diabetes, waist circumference and other risk factors for liver fibrosis in a nationally representative sample Peer-Reviewed Publication Keck School of Medicine of USC Women with certain cardiometabolic risk factors, including type 2 diabetes and high waist circumference, face a greater

Heart and metabolic risk factors more strongly linked to liver fibrosis in women than men, study finds Read More »

Many patients want to talk about their faith: Neurologists often don’t know how

March 9, 2026 / Clinical Practice / InnovateMed Author / neurologist

by University of California, Los Angeles edited by Sadie Harley, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source Credit: Ron Lach from Pexels People living with neurological diseases such as Parkinson’s disease, dementia, and epilepsy face not only physical decline, but also profound questions about identity, purpose, and meaning. Yet physicians best positioned to

Many patients want to talk about their faith: Neurologists often don’t know how Read More »

Machine learning finds four behavior symptom profiles tied to early dementia processes

March 9, 2026 / Research update / InnovateMed Author / dementia

by Annika Clemes, Karolinska Institutet edited by Lisa Lock, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source Credit: Pixabay/CC0 Public Domain Behavioral changes—such as anxiety, depression, irritability, apathy or agitation, collectively known as neuropsychiatric symptoms—may appear long before a dementia diagnosis. A new study from Karolinska Institutet and the University of Perugia, published in Alzheimer’s & Dementia,

Machine learning finds four behavior symptom profiles tied to early dementia processes Read More »

Childhood trauma doesn’t determine the future, 12-year study shows

March 9, 2026 / Patient education / InnovateMed Author / childhood trauma

by University of New South Wales edited by Sadie Harley, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source Credit: Unsplash/CC0 Public Domain Childhood trauma does not inevitably lead to poor outcomes in adulthood, new research from UNSW Sydney has found—and many people who experience adversity still thrive for decades afterwards. Abuse, bullying and household

Childhood trauma doesn’t determine the future, 12-year study shows Read More »

Biomimetic platform developed to enhance CAR T cell therapy against leukemia

March 9, 2026 / Research update / InnovateMed Author / leukemia

by Chinese Academy of Sciences edited by Gaby Clark, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source A Biomimetic Platform to Enhance CAR T Cell Therapy Against Leukemia. Credit: Li Feng Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by genetically engineering a chimeric antigen

Biomimetic platform developed to enhance CAR T cell therapy against leukemia Read More »

Zepbound vs. Compounded Tirzepatide: 5 Differences to Consider

March 9, 2026 / Patient education / InnovateMed Author / zepbound

Written by Alyssa Billingsley, PharmD | Reviewed by Christina Aungst, PharmD Published on February 5, 2026 coldsnowstorm/iStock via Getty Images Plus Key takeaways: Zepbound is an FDA-approved tirzepatide injection for weight loss. Compounded tirzepatide products are custom-made by compounding pharmacies and aren’t FDA approved. Zepbound has been evaluated in large clinical trials to show that it’s safe and effective.

Zepbound vs. Compounded Tirzepatide: 5 Differences to Consider Read More »

Generic Ozempic could be made for $28 a year, says analysis

March 9, 2026 / News update / InnovateMed Author / generic ozempic

The cost of weight loss medications is on the way down, with Novo Nordisk slashing list prices for Ozempic and Wegovy to $675 — half their current costs — next year. Direct-to-consumer prices are even less. But the semaglutide drugs remains unaffordable for lots of people in the U.S. and elsewhere. A new analysis suggests

Generic Ozempic could be made for $28 a year, says analysis Read More »